AsifAlaviMD

PubMed

• 130 citations
  Belumosudil for Chronic Graft-versus-Host Disease (cGVHD) After 2 or More Prior Lines of Therapy: The ROCKstar Study
  Corey Cutler, Stephanie J. Lee, Sally Arai, Marcello Rotta, Behyar Zoghi
  Blood. 2020-11-05
• 17 citations
  Three-Year Outcomes in Recipients of Mismatched Unrelated Bone Marrow Donor Transplants Using Post-Transplantation Cyclophosphamide: Follow-Up from a National Marrow D...
  Bronwen E Shaw, Antonio Martin Jimenez-Jimenez, Linda J Burns, Brent R Logan, Farhad Khimani
  Transplantation and Cellular Therapy. 2023-03-01
• 87 citations
  National Marrow Donor Program-Sponsored Multicenter, Phase II Trial of HLA-Mismatched Unrelated Donor Bone Marrow Transplantation Using Post-Transplant Cyclophosphamide
  Bronwen E. Shaw, Antonio Jimenez-Jimenez, Linda J. Burns, Brent R. Logan, Farhad Khimani
  Journal of Clinical Oncology. 2021-04-27

Journal Articles

• Minimal residual disease as a predictive factor for relapse after allogeneic hematopoietic stem Cell transplant in adult patients with acute myeloid leukemia in first ...  
  Grubovikj RM, Alavi A, Koppel A, Territo M, Schiller GJ, Cancers, 1/1/2012
• Tumor suppressor and T-regulatory functions of Foxp3 are mediated through separate signaling pathways  
  Heinze E, Chan G, Mory R, Khavari R, Alavi A, Chung SY, Nishimura RN, Weisbart RH, Oncology Letters, 1/1/2011

Abstracts/Posters

• Use of Thymoglobulin with Lower Dose of Busulfan Results in Less Acute Gvhd Following Unrelated Donor Allogeneic Stem Cell Transplantation for AML without Affecting Re...
  Asif Alavi, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
• Absolute Lymphocyte Count (ALC) Less Than 100 Predicts Adverse Transplant Outcomes with Rabbit Thymoglobulin in Patients Undergoing Matched Unrelated Allogeneic Hemato...
  Asif Alavi, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
• Maintenance Therapy after Second Autologous Stem Cell Transplant in Multiple Myeloma Improves Overall Survival
  Asif Alavi, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
• A pilot study of peripheral blood hematopoietic stem cell mobilization with the combination of Bortezomib and G-CSF in patients with Multiple Myeloma and Non-Hodgkin’s...
  Divaya Bhutani MD; Marie Ventimiglia B.S; Voravit Ratanatharathorn MD; Abhinav Deol MD; Lois Ayash MD; Asif Alavi MD; Lawrence G Lum MD DSc; Joseph P. Uberti MD, PhD;..., American Society of Hematology Annual Meeting, Orland, CA, 1/5/2015
• Accuracy of serum liver tests in predicting colorectal cancer recurrence in the liver
  Alavi A, Miller J, ACP Southern California Scientific Meeting, Huntington Beach, CA, 1/2/2011
• FOXP3 as a tumor suppressor: serial mutations to determine the domain responsible for tumor suppressor activity
  Alavi A, Mory R, Heinze E, Weisbart R, UCLA Solomon Scholar's Research Day, Los Angeles, CA, 1/8/2010
• Join now to see all

Lectures

• Haploidentical Stem Cell Transplantation at USC 
  Center for the Study of Blood Diseases, University of Southern California, Los Angeles, CA - 1/22/2015
• Blastic Plasmacytoid Dendritic Cell Neoplam 
  Center for the Study of Blood Diseases, University of Southern California, Los Angeles, CA - 1/28/2013
• How should we manage a patient with Stage IV DLBCL non-GC type? 
  Los Angeles, CA - 1/20/2013

Other

• Solitary Pulmonary Nodule 
  Alavi A, Kamangar N, eMedicine Pulmonology
  www.emedicine.com